Sign in
4

Changes in Ownership

Tempest Therapeutics, Inc. Filed Acc 0001179110-22-003378

Options or other derivatives

  • Director acquired 3,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Woiwode Thomas Director 2022-06-17 Grant or award · Stock Option (Right to Buy) +3,500 3,500 D
Loading xslF345X03/edgar.xml…